Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Tree

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 2, 2024
Is the digital rectal exam any good as a prostate cancer screening test?Mike Kirby, Samuel Wd Merriel, Oluwabunmi Olajide, et al.
Physics and Imaging in Radiation Oncology|July 14, 2021
Factors affecting accuracy and precision in ultrasound guided radiotherapyAlexander Grimwood, Karen Thomas, Sally Kember, et al.
International Journal of Radiation Oncology, Biology, Physics|January 13, 2026
2-year outcomes of the SPARC phase II trial: Simultaneous focal boost with stereotactic radiotherapy for localised intermediate to high-risk prostate cancerBinnaz Yasar, Yae-Eun Suh, Ewan Chapman, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2024
Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 TrialBinnaz Yasar, Yae-Eun Suh, Ewan Chapman, et al.
European Urology|July 21, 2015
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional AnalysisPiet Ost, Barbara Alicja Jereczek-Fossa, Nicholas Van As, et al.
BJU International|February 18, 2026
Characteristics and outcomes of men presenting with complications of metastatic prostate cancerArjun Nathan, Matthew G Parry, Adrian Cook, et al.
Clinical Genitourinary Cancer|May 7, 2021
Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223Adham Hijab, Sebastian Curcean, Nina Tunariu, et al.
Practical Radiation Oncology|May 8, 2026
Stereotactic body radiotherapy for locally advanced pancreatic adenocarcinoma: a systematic review and meta-analysis of prospective trialsK Liang Zeng, Alexander V Louie, Rupesh Kotecha, et al.
CA: a Cancer Journal for Clinicians|November 18, 2021
Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for cliniciansWilliam A Hall, Eric Paulson, X Allen Li, et al.
International Journal of Radiation Oncology, Biology, Physics|January 12, 2022
Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP TrialAlison Tree, Clare Griffin, Isabel Syndikus, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 2, 2024
Is the digital rectal exam any good as a prostate cancer screening test?Mike Kirby, Samuel Wd Merriel, Oluwabunmi Olajide, et al.
Physics and Imaging in Radiation Oncology|July 14, 2021
Factors affecting accuracy and precision in ultrasound guided radiotherapyAlexander Grimwood, Karen Thomas, Sally Kember, et al.
International Journal of Radiation Oncology, Biology, Physics|January 13, 2026
2-year outcomes of the SPARC phase II trial: Simultaneous focal boost with stereotactic radiotherapy for localised intermediate to high-risk prostate cancerBinnaz Yasar, Yae-Eun Suh, Ewan Chapman, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2024
Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 TrialBinnaz Yasar, Yae-Eun Suh, Ewan Chapman, et al.
European Urology|July 21, 2015
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional AnalysisPiet Ost, Barbara Alicja Jereczek-Fossa, Nicholas Van As, et al.
BJU International|February 18, 2026
Characteristics and outcomes of men presenting with complications of metastatic prostate cancerArjun Nathan, Matthew G Parry, Adrian Cook, et al.
Clinical Genitourinary Cancer|May 7, 2021
Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223Adham Hijab, Sebastian Curcean, Nina Tunariu, et al.
Practical Radiation Oncology|May 8, 2026
Stereotactic body radiotherapy for locally advanced pancreatic adenocarcinoma: a systematic review and meta-analysis of prospective trialsK Liang Zeng, Alexander V Louie, Rupesh Kotecha, et al.
CA: a Cancer Journal for Clinicians|November 18, 2021
Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for cliniciansWilliam A Hall, Eric Paulson, X Allen Li, et al.
International Journal of Radiation Oncology, Biology, Physics|January 12, 2022
Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP TrialAlison Tree, Clare Griffin, Isabel Syndikus, et al.
Pageof 7